Help us invent the future of pharmaceutical research.

Atomwise uses artificial intelligence to help discover new medicines. Based in San Francisco and funded by Data Collective, DFJ, and Khosla Ventures, we created the first Deep Learning Neural Network for drug discovery and design – AtomNet.

Over the last 2 years, AtomNet has been deployed to help invent new potential medicines for 27 disease targets. We work with leading research groups at top organizations including Harvard University, Stanford University, Scripps Research Institute, and several large pharmaceutical companies, advancing the frontiers of human health.

Atomwise’s notable successes have included promising compounds for the treatment of multiple sclerosis, Ebola, and botulinum neurotoxin, as well as work in cancer, malaria, and metabolic diseases. Today, Atomwise searches 1 million potential drug molecules every 24 hours.

We invite you to read more about Atomwise on arXiv, BBC, Vice, NPR, The Wall Street Journal, and TechCrunch.